RE:undervalued or overhypedThe reason this is a .10 stock is because it's not being promoted well. This company has the goods but doesn't get the proper promotion down south. I see a lot of otc biotechs out of the US with way less than what Sirona has and with Mcaps well over 60 million but closer to 100 million . here SBM sits at just under 14 Mcap. They need a good promo and social media budget.